Strana 1 z 16 Výsledek
I. FIELD OF INVENTION
The present invention relates to the field of cancer treatment and is based on the discovery that betulinic acid and its derivatives are potent anti-neuroectodermal agents. As disclosed herein, betulinic acid and its derivatives are useful for the treatment of neurodectodermal
FIELD OF THE INVENTION
This invention relates to the use of betulinic acid derivatives for the inhibition and or prevention of cancer growth. The invention also relates to novel betulinic acid derivatives useful for inhibition of tumor or cancer cells and a process for the preparation of the
FIELD OF THE INVENTION
The invention relates to the use of betulinic acid and its derivatives for the inhibition and/or prevention or cancer growth. The invention also relates to novel betulinic acid derivatives useful for the inhibition of tumor/cancer cells and a process for the preparation of the
FIELD OF THE INVENTION
The invention relates to use of betulinic acid and/or its derivatives for treating, inhibiting, and/or preventing tumors or cancer growth more particularly, to treating leukemia, lymphomas, lung, prostate and ovarian cancer. This invention also relates to novel betulinic acid
FIELD OF THE INVENTION
This invention relates to novel betulinic acid derivatives and a composition containing betulinic acid derivatives, processes for preparation of such betulinic acid derivatives and method of treatment of tumor and such proliferative disease using these derivatives. This
FIELD OF THE INVENTION
The present invention relates to betulonic and betulinic acid derivatives and, in particular, to C-28 and C-3 derivatives. The present invention relates to betulonic acid esters, dihydro-betulonic acid esters, PAG-modified betulinic acid derivatives, and PAG-modified
FIELD OF THE INVENTION
The present invention relates to betulonic and betulinic acid derivatives and, in particular, to C-28 and C-3 derivatives. The present invention relates to betulonic acid esters, dihydro-betulonic acid esters, PAG-modified betulinic acid derivatives, and PAG-modified
FIELD OF THE INVENTION
The present invention relates to compositions and methods of inhibiting tumors and, more particularly, of treating a malignant tumor, like a melanoma, using plant-derived compounds and derivatives thereof, and in particular, prodrugs of betulinic acid and betulinic acid
FIELD OF THE INVENTION
The present invention relates to compositions and methods of inhibiting tumors and, more particularly, of treating a malignant tumor, like a melanoma, using plant-derived compounds and derivatives thereof, and in particular, prodrugs of betulinic acid and betulinic acid
FIELD OF THE INVENTION
This invention relates to compositions and methods of inhibiting tumor growth and, more particularly, to treating a malignant tumor using plant-derived compounds and derivatives thereof.
BACKGROUND OF THE INVENTION
Over the past four decades the incidence of melanoma has been
This application is a 371 of PCT/IN2005/000445 filed Dec. 29, 2005.
FIELD OF THE INVENTION
The present invention relates to novel betulinic acid derivatives of formula (I), exhibiting useful activity in the inhibition of tumor cancer cells and in particular possessing improved pharmacokinetics over
This application is a national phase application under 35 U.S.C. .sctn. 371 of International Application No. PCT/AT2004/000045 filed 11 Feb. 2004, which claims priority to Austrian Application No. A 200/2003 filed 11 Feb. 2003. The entire text of each of the above-referenced disclosures is
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals. Like
FIELD OF THE INVENTION
This invention relates to compositions and methods of selectively inhibiting tumors and, more particularly, to treating a malignant melanoma using plant-derived compounds and derivatives thereof.
BACKGROUND OF THE INVENTION
Over the past four decades the incidence of melanoma
FIELD OF THE INVENTION
This invention relates to compositions and methods of selectively inhibiting tumors and, more particularly, to treating a malignant melanoma using plant-derived compounds and derivatives thereof.
BACKGROUND OF THE INVENTION
Over the past four decades the incidence of melanoma